Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Do specific antimicrobial stewardship interventions have an impact on carbapenem resistance in Gram-negative bacilli? A multicentre quasi-experimental ecological study: time-trend analysis and characterization of carbapenemases.
Álvarez-Marín R, López-Cerero L, Guerrero-Sánchez F, Palop-Borras B, Rojo-Martín MD, Ruiz-Sancho A, Herrero-Rodríguez C, García MV, Lazo-Torres AM, López I, Martín-Hita L, Nuño-Álvarez E, Sánchez-Yebra W, Galán-Sánchez F, Reguera-Iglesias JM, Lepe JA, Peñalva G, Pascual Á, Cisneros JM; CarbaPIRASOA team. Álvarez-Marín R, et al. J Antimicrob Chemother. 2021 Jun 18;76(7):1928-1936. doi: 10.1093/jac/dkab073. J Antimicrob Chemother. 2021. PMID: 33769481
First identification of blaNDM-1 carbapenemase in blaOXA-94-producing Acinetobacter baumannii ST85 in Spain.
Fernández-Cuenca F, Pérez-Palacios P, Galán-Sánchez F, López-Cerero L, López-Hernández I, López Rojas R, Arca-Suárez J, Díaz-de Alba P, Rodríguez Iglesias M, Pascual A. Fernández-Cuenca F, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2020 Jan;38(1):11-15. doi: 10.1016/j.eimc.2019.03.008. Epub 2019 May 4. Enferm Infecc Microbiol Clin (Engl Ed). 2020. PMID: 31060865 Free article. English, Spanish.
Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 Clone.
Arca-Suárez J, Fraile-Ribot P, Vázquez-Ucha JC, Cabot G, Martínez-Guitián M, Lence E, González-Bello C, Beceiro A, Rodríguez-Iglesias M, Galán-Sánchez F, Bou G, Oliver A. Arca-Suárez J, et al. Antimicrob Agents Chemother. 2019 Sep 23;63(10):e01110-19. doi: 10.1128/AAC.01110-19. Print 2019 Oct. Antimicrob Agents Chemother. 2019. PMID: 31383659 Free PMC article.
Evolution of the antimicrobial resistance rates in clinical isolates of Pseudomonas aeruginosa causing invasive infections in the south of Spain.
Fernández-Cuenca F, Martínez-Martínez L, Pascual Á; Grupo GRAM; Miembros del Grupo GRAM. Fernández-Cuenca F, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2020 Apr;38(4):150-154. doi: 10.1016/j.eimc.2019.06.009. Epub 2019 Aug 7. Enferm Infecc Microbiol Clin (Engl Ed). 2020. PMID: 31399254 English, Spanish.
Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection.
Arca-Suárez J, Vázquez-Ucha JC, Fraile-Ribot PA, Lence E, Cabot G, Martínez-Guitián M, Lasarte-Monterrubio C, Rodríguez-Iglesias M, Beceiro A, González-Bello C, Galán-Sánchez F, Oliver A, Bou G. Arca-Suárez J, et al. J Antimicrob Chemother. 2020 Nov 1;75(11):3209-3217. doi: 10.1093/jac/dkaa291. J Antimicrob Chemother. 2020. PMID: 32728723
Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections.
Arca-Suárez J, Lasarte-Monterrubio C, Rodiño-Janeiro BK, Cabot G, Vázquez-Ucha JC, Rodríguez-Iglesias M, Galán-Sánchez F, Beceiro A, González-Bello C, Oliver A, Bou G. Arca-Suárez J, et al. J Antimicrob Chemother. 2021 Jan 1;76(1):91-100. doi: 10.1093/jac/dkaa396. J Antimicrob Chemother. 2021. PMID: 33083833
Revisiting the epidemiology of bloodstream infections and healthcare-associated episodes: results from a multicentre prospective cohort in Spain (PRO-BAC Study).
Pérez-Crespo PMM, Lanz-García JF, Bravo-Ferrer J, Cantón-Bulnes ML, Sousa Domínguez A, Goikoetxea Aguirre J, Reguera-Iglesias JM, León Jiménez E, Armiñanzas Castillo C, Mantecón Vallejo MÁ, Marrodan Ciordia T, Fernández Suárez J, Boix-Palop L, Cuquet Pedragosa J, Jover Saenz A, Sevilla Blanco J, Galán-Sánchez F, Natera Kindelán C, Del Arco Jiménez A, Bahamonde-Carrasco A, Smithson Amat A, Vinuesa García D, Herrero Rodríguez C, Reche Molina IM, Pérez Camacho I, Sánchez-Porto A, Guzmán García M, Becerril Carral B, Merino de Lucas E, López-Hernández I, Rodríguez-Baño J, López-Cortés LE; PROBAC REIPI/GEIH-SEIMC/SAEI Group. Pérez-Crespo PMM, et al. Int J Antimicrob Agents. 2021 Jul;58(1):106352. doi: 10.1016/j.ijantimicag.2021.106352. Epub 2021 May 4. Int J Antimicrob Agents. 2021. PMID: 33961992
Pseudomonas aeruginosa Community-Onset Bloodstream Infections: Characterization, Diagnostic Predictors, and Predictive Score Development-Results from the PRO-BAC Cohort.
Martínez Pérez-Crespo PM, Rojas Á, Lanz-García JF, Retamar-Gentil P, Reguera-Iglesias JM, Lima-Rodríguez O, Del Arco Jiménez A, Fernández Suárez J, Jover-Saenz A, Goikoetxea Aguirre J, León Jiménez E, Cantón-Bulnes ML, Ortega Lafont P, Armiñanzas Castillo C, Sevilla Blanco J, Cuquet Pedragosa J, Boix-Palop L, Becerril Carral B, Bahamonde-Carrasco A, Marrodan Ciordia T, Natera Kindelán C, Reche Molina IM, Herrero Rodríguez C, Pérez Camacho I, Vinuesa García D, Galán-Sánchez F, Smithson Amat A, Merino de Lucas E, Sánchez-Porto A, Guzmán García M, López-Hernández I, Rodríguez-Baño J, López-Cortés LE, On Behalf Of The Probac Reipi/Geih-Seimc/Saei Group. Martínez Pérez-Crespo PM, et al. Antibiotics (Basel). 2022 May 24;11(6):707. doi: 10.3390/antibiotics11060707. Antibiotics (Basel). 2022. PMID: 35740114 Free PMC article.
81 results